Reuters (May 2)
2023/ 05/ 02 by jd in Global News
“Diversifying abroad looks attractive to many Japanese companies given weak home markets” as demonstrated by Astellas recent $5.9 billion acquisition of Iveric Bio. “For the $28 billion drugmaker, which already earns the bulk of its revenue from overseas, exceptionally low borrowing costs at home may have boosted its offshore appetite even more.”
Tags: Acquisition, Astellas, Attractive, Borrowing costs, Diversifying, Drugmaker, Home markets, Iveric Bio, Japanese, Offshore appetite, Overseas, Revenue, Weak
